News & Updates
  • Home
  • About Us
  • Contact
  • Home 1
  • News & Updates

    Key Takeaways from the 468th CIBRC Meeting: Multiple Agrochemical Approvals Under Section 9(3) for Syngenta, Sumitomo, UPL, Atul, Rallis & Others

    Patented New ISO Name Approved – January 2026: Pendiclofenate, a new phenoxyacetic acid herbicide derivative compound from Corteva Agriscience

    Tomovircona, a Novel RNAi-Based Virucide by Silicon Gene Technologies (Shanghai) Co., Ltd., Receives ISO approval

    Tiziana Announces Submission of Amendment to Investigational New Drug Application to Advance Oral Foralumab, a Fully Human Anti-CD3 Monoclonal Antibody, in Patients with Crohn’s Disease

    adminFebruary 7, 202202.2k views

    Summary – – Tiziana is Developing the First Oral Form of Foralumab in a Convenient Capsule to be Evaluated in Phase 1b…

    Read more

    Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook

    adminFebruary 7, 202202.6k views

    Summary : Liver cancer, also known as hepatic cancer and primary hepatic cancer, is a relatively rare form of cancer that has…

    Read more

    mdgroup Newly Appointed Medical Director Dr Arthur Lazarus Addresses Remote Patient Healthcare Selection at SCOPE 2022

    adminFebruary 7, 202202k views

    Synopsis : mdgroup, the leading global provider of personalised clinical study services, has appointed Dr Arthur Lazarus as Medical Director. Dr Lazarus…

    Read more

    FDA Pushes Pfizer COVID Vaccine for 6 Month to 5 Years Kids

    adminFebruary 7, 202201.8k views

    Summary : A good news is brewing for kids as the COVID-19 vaccine for the age group younger than 5 years old…

    Read more

    Fast Radius Announces Completion of Merger with ECP Environmental Growth Opportunities Corp.

    adminFebruary 6, 202201.8k views

    Summary : Fast Radius will trade on Nasdaq under ticker symbol “FSRD” “Fast Radius”), a cloud manufacturing company, today announced the successful…

    Read more

    ION receives continued listing standard notice from the NYSE

    adminFebruary 5, 202201.7k views

    Synopsis : ION Geophysical Corporation (NYSE: IO) today announced that it received notice on January 31, 2022 from the New York Stock…

    Read more

    FDA approves Enjaymo™ (sutimlimab-jome), First Treatment for use in Patients with Cold Agglutinin Disease

    adminFebruary 5, 202202.6k views

    Summary : FDA approves Enjaymo™ (sutimlimab-jome), first treatment for use in patients with cold agglutinin disease Enjaymo is the only approved treatment…

    Read more

    Yumanity Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

    adminFebruary 5, 202201.7k views

    Synopsis : Yumanity Therapeutics (NASDAQ: YMTX), a clinical-stage biopharmaceutical company focused on the discovery and development of innovative, disease-modifying therapies for neurodegenerative…

    Read more

    Sanofi Unites as One Under New Logo, Structure

    adminFebruary 5, 202202.3k views

    Synopsis : Sanofi has been a global healthcare leader that has brought forth treatments for rare diseases and established standard-of-care therapeutics for…

    Read more

    Financials Indicate Novartis’ Sandoz Division Could Be a Tough Sell

    adminFebruary 5, 202201.9k views

    Synopsis : Novartis reported its full-year financials this week for 2021, and overall, the news was good. Full-year net sales grew 4%,…

    Read more

    Posts navigation

    1 … 49 … 105
    View Desktop Version

    Powered by PenciDesign

    Back To Top